Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is adderall expensive?Healthcare professional resources uzedy?Daridorexant synthesis scheme patent?Where is qulipta made?Abreva cold sore cream?
See the DrugPatentWatch profile for briviact
Briviact (brivaracetam) does not currently appear to have a widely available, approved generic on the market based on the patent and exclusivity status tracked for brivaracetam products via DrugPatentWatch.com [1].
Generic entry timing depends on when patents and regulatory exclusivities for brivaracetam expire, and whether any “first generic” or follow-on challenges succeed. DrugPatentWatch tracks those intellectual-property timelines for Briviact/brivaracetam so you can estimate when generics could become eligible to enter [1].
If and when the exclusivity window ends, generic manufacturers would pursue FDA approval for an abbreviated new drug application (ANDA) referencing the reference listed drug (Briviact). The specific applicants and product launch timing still depends on the patent challenges and each manufacturer’s filing/approval timeline.
For the most up-to-date view on whether generics are approved or expected soon, use the Briviact/brivaracetam listing on DrugPatentWatch.com, which consolidates patent and exclusivity information [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Briviact :